Dry Eye Disease

Dry Eye Disease Market is valued around USD 2796.8 Million in 2018 and expected to reach USD 3778.1 Million by 2025 with the CAGR of 4.7% over the forecast period. Increase in geriatric population and various environmental factors are the key drivers for Global Dry Eye Disease Market.

Dry eye disease market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about dry eye disease market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with product type, distribution channel.

Dry eye disease is caused due to the lack of tears or lubrication in eyes which led to the burning sensation and redness in eyes. These tears provide lubrication and each blink spread tears evenly and provide nourishment to the eyes. When the production and drainage of tears are not balanced then it leads to the dry eye disease. This condition is most commonly occurs in older population and there are various environmental conditions which are responsible for such condition in young adults as well. The few symptoms experienced by the people suffering from dry eye disease are irritation, burning sensation, blurred vision and advanced stage may also lead to the vision impairment.

There are various factors driving the growth of the dry eye disease market, one of the major factors driving the growth of this market is increasing geriatric population. Due to the weakening of muscles and glands in geriatric people it is most common condition among them. As per Population Reference Bureau report, the number of Americans ages 65 and older is projected to more than double from 46 million today to over 98 million by 2060, and the 65-and-older age group’s share of the total population will rise to nearly 24 percent from 15 percent.  Furthermore, there are various research and development activities carried by major players which led to the development of novel drugs and devices for the treatment of this condition. Moreover, there is a constant increase in population and various other environmental factors which may affect the tear production which led to the dry eye disease. However, stringent regulations and high cost of dry eye disease are expected inhibit the growth of dry eye disease market over the forecast period.

Global dry eye disease market report covers prominent players like Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Allergan plc, Shire plc, TRB Chemedica International SA, Mitotech S.A., Sun Pharmaceutical Industries Ltd., Senju Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., Valeant Pharmaceuticals International, Inc., Otsuka Pharmaceutical Co., Ltd., Novartis AG, FCI S.A.S. and others.

Dry Eye Disease Market Segmentation –

By Product Type 

Artificial Tears
Anti-inflammatory Drugs
Punctal Plugs
Secretagogue
By Distribution Channel 

Hospital Pharmacies
Independent Pharmacies and Drug Stores
Online Pharmacies
By Region

North America
U.S.
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Dry Eye Disease Market key Players
Santen Pharmaceutical Co., Ltd.
Johnson & Johnson
Allergan plc
Shire plc
TRB Chemedica International SA
Mitotech S.A.
Sun Pharmaceutical Industries Ltd.
Senju Pharmaceutical Co., Ltd.
Sentiss Pharma Pvt. Ltd.

Interested in this report?

Get your sample now!

Download Sample